期刊
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17
卷 17, 期 -, 页码 143-163出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-bioeng-071813-104927
关键词
signal transduction; cancer; therapeutics; mathematical modeling; systems pharmacology
资金
- BBSRC [BBS/E/B/000C0419, BBS/E/B/0000H248] Funding Source: UKRI
- Cancer Research UK [14867] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0419, BBS/E/B/0000C199, BBS/E/B/0000H248] Funding Source: Medline
- Medical Research Council Funding Source: Medline
- Worldwide Cancer Research [12-1259] Funding Source: Medline
Cell signaling pathways control cells' responses to their environment through an intricate network of proteins and small molecules partitioned by intracellular structures, such as the cytoskeleton and nucleus. Our understanding of these pathways has been revised recently with the advent of more advanced experimental techniques; no longer are signaling pathways viewed as linear cascades of information flowing from membrane-bound receptors to the nucleus. Instead, such pathways must be understood in the context of networks, and studying such networks requires an integration of computational and experimental approaches. This understanding is becoming more important in designing novel therapies for diseases such as cancer. Using the MAPK (mitogen-activated protein kinase) and PI3K (class I phosphoinositide-3' kinase) pathways as case studies of cellular signaling, we give an overview of these pathways and their functions. We then describe, using a number of case studies, how computational modeling has aided in understanding these pathways' deregulation in cancer, and how such understanding can be used to optimally tailor current therapies or help design new therapies against cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据